Silvercrest Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.44M Buy
16,595
+191
+1% +$18.3K 0.01% 564
2025
Q4
$1.58M Sell
16,404
-1,497
-8% -$145K 0.01% 561
2025
Q3
$1.7M Sell
17,901
-258
-1% -$23.7K 0.01% 552
2025
Q2
$1.58M Sell
18,159
-2,960
-14% -$251K 0.01% 579
2025
Q1
$1.9M Buy
21,119
+3,419
+19% +$306K 0.01% 551
2024
Q4
$1.41M Sell
17,700
-623
-3% -$53.9K 0.01% 567
2024
Q3
$1.65M Sell
18,323
-127
-0.7% -$10.7K 0.01% 517
2024
Q2
$1.45M Buy
18,450
+2,082
+13% +$171K 0.01% 567
2024
Q1
$1.43M Sell
16,368
-32
-0.2% -$2.73K 0.01% 553
2023
Q4
$1.35M Sell
16,400
-6,724
-29% -$512K 0.01% 548
2023
Q3
$1.81M Sell
23,124
-100
-0.4% -$8.37K 0.01% 498
2023
Q2
$2.05M Buy
23,224
+181
+0.8% +$15.6K 0.01% 485
2023
Q1
$1.86M Buy
23,043
+200
+0.9% +$16.3K 0.01% 487
2022
Q4
$1.78M Sell
22,843
-2,565
-10% -$208K 0.01% 491
2022
Q3
$2.05M Sell
25,408
-1,200
-5% -$108K 0.02% 440
2022
Q2
$2.39M Sell
26,608
-260
-1% -$26.3K 0.02% 439
2022
Q1
$2.98M Sell
26,868
-579
-2% -$61.2K 0.02% 445
2021
Q4
$2.84M Sell
27,447
-70,979
-72% -$8.22M 0.02% 445
2021
Q3
$12.3M Sell
98,426
-1,586
-2% -$205K 0.08% 235
2021
Q2
$12.4M Buy
100,012
+2,210
+2% +$277K 0.08% 242
2021
Q1
$11.6M Buy
97,802
+706
+0.7% +$82.7K 0.08% 244
2020
Q4
$11.4M Buy
97,096
+656
+0.7% +$72.2K 0.08% 227
2020
Q3
$10M Buy
96,440
+756
+0.8% +$75.9K 0.09% 229
2020
Q2
$8.77M Buy
95,684
+1,777
+2% +$170K 0.08% 233
2020
Q1
$8.47M Buy
93,907
+5,996
+7% +$638K 0.09% 212
2019
Q4
$9.97M Sell
87,911
-103
-0.1% -$11.3K 0.08% 232
2019
Q3
$9.56M Buy
88,014
+1,149
+1% +$120K 0.08% 226
2019
Q2
$8.46M Buy
86,865
+82
+0.1% +$7.49K 0.08% 185
2019
Q1
$7.9M Buy
86,783
+346
+0.4% +$31K 0.08% 187
2018
Q4
$7.86M Sell
86,437
-1,125
-1% -$105K 0.09% 183
2018
Q3
$8.61M Sell
87,562
-6,387
-7% -$590K 0.08% 189
2018
Q2
$8.04M Buy
93,949
+587
+0.6% +$49K 0.08% 200
2018
Q1
$7.49M Buy
93,362
+13,001
+16% +$1.07M 0.07% 202
2017
Q4
$6.49M Buy
80,361
+1,070
+1% +$85.7K 0.06% 213
2017
Q3
$6.17M Buy
79,291
+19,130
+32% +$1.59M 0.06% 209
2017
Q2
$5.34M Buy
60,161
+3,290
+6% +$277K 0.06% 217
2017
Q1
$4.58M Buy
56,871
+2,024
+4% +$158K 0.05% 230
2016
Q4
$3.91M Buy
54,847
+30,786
+128% +$2.42M 0.04% 243
2016
Q3
$2.08M Sell
24,061
-6,075
-20% -$529K 0.03% 290
2016
Q2
$2.62M Buy
30,136
+11
+0% +$890 0.03% 267
2016
Q1
$2.26M Sell
30,125
-2,046
-6% -$154K 0.03% 271
2015
Q4
$2.48M Sell
32,171
-9,068
-22% -$683K 0.03% 277
2015
Q3
$2.76M Sell
41,239
-637
-2% -$46.9K 0.04% 238
2015
Q2
$3.1M Buy
41,876
+8,303
+25% +$634K 0.04% 264
2015
Q1
$2.62M Buy
33,573
+6,470
+24% +$490K 0.04% 246
2014
Q4
$1.96M Buy
27,103
+56
+0.2% +$3.89K 0.03% 273
2014
Q3
$1.68M Sell
27,047
-700
-3% -$44.5K 0.03% 281
2014
Q2
$1.77M Buy
27,747
+550
+2% +$33.4K 0.03% 277
2014
Q1
$1.67M Hold
27,197
0.03% 275
2013
Q4
$1.56M Hold
27,197
0.03% 282
2013
Q3
$1.45M Sell
27,197
-930
-3% -$50K 0.03% 278
2013
Q2
$1.45M Buy
+28,127
New +$1.39M 0.03% 272

Other funds holding MDT

Silvercrest Asset Management's MDT Position: Q1 2026 in Review

Silvercrest Asset Management increased its Medtronic (MDT) stake by 1.2% in Q1 2026, buying an estimated $18.3K and bringing the position to 16,595 shares worth $1.44M. The position accounts for 0.01% of the portfolio, ranked #564.

Silvercrest Asset Management first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $12.4M in Q2 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Silvercrest Asset Management held 16,595 shares of Medtronic worth $1.44M as of Q1 2026.
  • Silvercrest Asset Management bought 191 Medtronic shares in Q1 2026, an estimated $18.3K.
  • Medtronic made up 0.01% of Silvercrest Asset Management's portfolio in Q1 2026, its #564 holding.
  • Silvercrest Asset Management first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Silvercrest Asset Management's Medtronic position peaked at $12.4M in Q2 2021.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Silvercrest Asset Management's 13F filing for Q1 2026, filed 15 May 2026.